Coupling of RNAi-mediated target downregulation with gene replacement

Antisense and Nucleic Acid Drug Development

Volumn 13, Issue 3, 2003, Pages 151-155

  Kim, Dong Ho ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CODON; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; GENE EXPRESSION; GENE REPLACEMENT; GENETIC PROCEDURES; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA PROCESSING; GENE REPLACEMENT THERAPY; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTANT; PROTEIN TARGETING; WILD TYPE;

ANIMALIA;

EID: 24144492099     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729003768247619     Document Type: Article

References (14)

1. BROOK, J.D., MCCURRACH, M.E., HARLEY, H.G., BUCKLER, A.J., CHURCH, D., ABURATANI, H., HUNTER, K., STANTON, V.P., THIRION, J.P., HUDSON, T., et al. (1992). Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799-808.
2. CUMMINGS, C.J., and ZOGHBI, H.Y. (2000). Fourteen and counting: Unraveling trinucleotide repeat diseases. Hum. Mol. Genet. 9, 909-916.
3. DITTMER, D., PATI, S., ZAMBETTI, G., CHU, S., TERESKY, A.K., MOORE, M., FINLAY, C., and LEVINE A.J. (1993). Gain of function mutations in p53. Nat. Genet. 4, 42-46.
4. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001a). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
5. ELBASHIR, S.M., MARTINEZ, J., PATKANIWSKA, A., LENDECKEL, W., and TUSCHL, T. (2001b). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
6. GITLIN, L., KARELSKY, S., and ANDINO, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418, 430-434.
7. KERN, S.E., PIETENPOL, J.A., THIAGALINGAM, S., SEYMOUR, A., KINZLER, K.W., and VOGELSTEIN, B. (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 8, 827-830.
8. LASSUS, P., RODRIGUEZ, J., and LAZEBNIK, Y. (2002). Confirming specificity of RNAi in mammalian cells. Science STKE, 147, PL 13.
9. LEE, N., DOHJIMA, T., BAUER, G., LI, H., LI, M., ESHANI, A., SALVATERRA, P., and ROSSI, J. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 19, 500-504.
10. MAHADEVAN, M., TSILFIDIS, C., SABOURIN, L., SHUTLER, G., AMEMIYA, C., JANSEN, G., NEVILLE, C., NARANG, M., BARCELO, J., O'HOY, K., et al. (1992). Myotonic dystrophy mutation: An unstable CTG repeat in the 3′-untranslated region of the gene. Science 255, 1253-1255.
11. MARTINEZ, L.A., NEGUIBNEVA, I., LEHRMANN, H., VERVISCH, A., TCHENIO, T., LOZANO, G., and HAREL-BELLAN, A. (2002). Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc. Natl Acad. Sci. USA 99, 14849-14854.
12. POMERANTZ, J.L., DENNY, E.M., and BALTIMORE, D. (2002). CARD 11 mediates factor-specific of NF kappa beta by the T-cell receptor complex. EMBO J. 21, 5184-5194.
13. SIGAL, A., and ROTTER, V. (2000). Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 60, 6788-6793.
14. TUSCHL, T., ZAMORE, P.D., LEHMANN, R., BARTEL, D.P., and SHARP, P.A. (1999). Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13, 3191-3197.